TY  - JOUR
AU  - Muñoz-Jurado, Ana
AU  - Escribano, Begoña M
AU  - Agüera, Eduardo
AU  - Caballero-Villarraso, Javier
AU  - Galvan, Alberto
AU  - Tunez, Isaac
PY  - 2022
DO  - 10.1007/s00415-022-11237-1
UR  - http://hdl.handle.net/10668/20019
T2  - Journal of neurology
AB  - The SARS-CoV-2 pandemic has raised particular concern for people with Multiple Sclerosis, as these people are believed to be at increased risk of infection, especially those being treated with disease-modifying therapies. Therefore, the objective of...
LA  - en
PB  - Springer
KW  - Adjuvant treatments
KW  - Disease-modifying therapies
KW  - Immunity
KW  - Multiple sclerosis
KW  - Neuro-COVID
KW  - SARS-CoV-2
KW  - Antibodies, viral
KW  - COVID-19
KW  - COVID-19 vaccines
KW  - Humans
KW  - Multiple sclerosis
KW  - SARS-CoV-2
KW  - Post-acute COVID-19 syndrome
TI  - SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19.
TY  - research article
VL  - 269
ER  -